COR THERAPEUTICS/ORTHO THROMBIN RECEPTORS R&D COLLABORATION
Executive Summary
COR THERAPEUTICS/ORTHO THROMBIN RECEPTORS R&D COLLABORATION has as a "key" goal the discovery of "peptide and small molecule agonists and antagonists of the thrombin receptor," Cor announced Dec. 22. The thrombin receptors would have potential applications for cardiovascular therapies, osteoporosis, wound healing and CNS disorders, the South San Francisco-based biopharmaceutical R&D company explained.